Boston Scientific: Adding Another Growth Engine With Penumbra
Source: SeekingAlpha
2026-01-16 07:34:49 ET
Towards the end of October, I concluded that Boston Scientific ( BSX ) was continuing its M&A playbook, just as organic achievements were impressive. Supported by nearly 20% organic sales growth, shares commanded premium earnings valuations in the low thirties, and while this was demanding, as impressive was the organic growth trajectory....
Read the full article on Seeking Alpha
For further details see:
Boston Scientific: Adding Another Growth Engine With Penumbra
Penumbra Inc.
NASDAQ: PEN
PEN Trading
0.27% G/L:
$336.59 Last:
199,164 Volume:
$336.19 Open:
PEN Latest News
PEN Stock Data
$13,316,119,234
37,517,366
0.09%
173
N/A
Medical Equipment & Supplies
Healthcare
US
Alameda
